Key facts
- Clue’s last known valuation is $72.3M (Oct 2023).
- It has raised $73.5M; the latest was Later Stage VC in Feb 2026.
- Notable investors include FJ Labs, Union Square Ventures, Balderton Capital, Molten Ventures, Hoxton Ventures — 37 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 37 names
- ·Watchlist + deal alerts for Clue
- ·The full record, as it builds
Funding rounds
No funding rounds for Clue are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Clue
Developer of a mobile application designed to track the fertility cycle. The company's application analyzes information about the menstruation cycle and fertile window, gives predictions, sets calendar reminders, and helps to track and find patterns in symptoms and manage menstrual health, enabling women to enhance menstrual and reproductive health.
- Sector
- Healthcare
- HQ
- Berlin, Germany
- Founded
- 2012
- Employees
- 148
- Website
- helloclue.com/
- Ownership
- Privately Held (backing)
Clue doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Clue shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Clue in its N-PORT filings yet. We sweep new filings monthly.